Page last updated: 2024-11-02

4-phenylbutyric acid and Uremia

4-phenylbutyric acid has been researched along with Uremia in 1 studies

4-phenylbutyric acid: RN refers to the parent cpd
4-phenylbutyric acid : A monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation.

Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zeng, W1
Guo, YH1
Qi, W1
Chen, JG1
Yang, LL1
Luo, ZF1
Mu, J1
Feng, B1

Other Studies

1 other study available for 4-phenylbutyric acid and Uremia

ArticleYear
4-Phenylbutyric acid suppresses inflammation through regulation of endoplasmic reticulum stress of endothelial cells stimulated by uremic serum.
    Life sciences, 2014, May-08, Volume: 103, Issue:1

    Topics: Cell Proliferation; Chemokine CCL2; Culture Media; Endoplasmic Reticulum Chaperone BiP; Endoplasmic

2014